H. Lundbeck
Pharmaceutical research, development and manufacturing focused on treatments for brain diseases and mental health conditions
Highlights
- New on EvolcAdded 2026-10-29
Recent signals
What changed at H. Lundbeck in the last 6 months, newest first. Each line links to its public source.
- 10 Nov 2026 In the news · Lundbeck raises its full-year guidance prnewswire.com
About H. Lundbeck
Lundbeck is a pharmaceutical company focused on brain diseases. Its work spans research, development, manufacturing and commercialization of pharmaceutical products.
Its products treat neurological and psychiatric disorders, including depression, anxiety, psychosis, Parkinson’s disease and Alzheimer’s disease. The company serves people living with these conditions through pharmaceutical therapies.
The Finnish legal entity is Oy H. Lundbeck Ab, based in Turku, and was founded in 1928. Lundbeck describes itself as a global company with offices worldwide.
Product: Researches, develops, manufactures and commercializes pharmaceutical treatments for brain diseases and mental health conditions.
Public tenders won
3 tenders won since 1 Jan 2024 from 3 public buyers in Finland, worth €136.0M as awarded. From EU award notices (TED) that name H. Lundbeck by its registry number.
- 8 Sep 2026 Pohjois-Pohjanmaan hyvinvointialue · Lääkevalmisteet ja niihin rinnastettavat tuotteet hankintakaudelle 1.1.2026-31.12.2027 · €142 notice
- 10 Mar 2025 Vankiterveydenhuollon yksikkö · Jälki-ilmoitus. Lääkevalmisteiden ja niihin rinnastettavien tuotteiden hankintaa koskeva tarjouspyyntö hankintakaudelle 2025-2026 · €6.0M notice
- 12 Apr 2024 Sansia Oy · Lääkevalmisteet sekä niihin rinnastettavat valmisteet Itä-Suomen yhteistyöalueelle · €130.0M notice
Jobs at H. Lundbeck
Leadership
- Charl van Zyl · President & CEOSource: company website
More biotech & pharma companies
HumGel
Human tumor-derived cell matrix (MyoGel) for cancer research labs running invasion and drug-testing assaysYoung companyNew on EvolcHytest
Immunological reagents, antibodies and antigens for IVD manufacturers and research labsNew on EvolcKÄÄPÄ BioTech
Standardised functional mushroom extracts for pharmaceutical, nutraceutical and wellness product developersNew on EvolcKaro Healthcare
Consumer healthcare company marketing everyday health products in over 90 markets, mainly Europe and the Nordic countriesNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- AWS
- Apache